Ozempic, a semaglutide injection initially approved by the FDA for type 2 diabetes, proves to be highly effective in promoting weight loss. This breakthrough medication mimics the hormone GLP-1, targeting brain areas that regulate appetite and food intake. Starting with a 0.25 mg per week dose, Ozempic is gradually increased to 1 mg, tailored to patients’ tolerance and therapeutic response